Mars Licenses Pairwise’s Fulcrum® Gene Editing Platform
Pairwise has closed a $40 million Series C funding round, led by Deerfield Management, with new investment from Corteva Inc., along with returning investors Aliment Capital and Leaps by Bayer.
Pairwise has closed a $40 million Series C funding round, led by Deerfield Management, with new investment from Corteva Inc., along with returning investors Aliment Capital and Leaps by Bayer.
Plant Science Companies are expanding gene editing and biosolutions to enhance crop resilience and sustainability.
To provide the best experience, we use technologies like cookies to store and access device information.